Hepatic regulation of platelet-activating factor acetylhydrolase and lecithin: Cholesterol acyltransferase biliary and plasma output in rats exposed to bacterial lipopolysaccharide
Open Access
- 1 July 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 30 (1) , 128-136
- https://doi.org/10.1002/hep.510300122
Abstract
Normal rat bile contains secretory platelet-activating factor acetylhydrolase (PAF-AH), the enzyme capable of hydrolyzing the inflammatory mediator platelet-activating factor (PAF), and phospholipids containing oxidized truncated fatty acids. Because lecithin:cholesterol acyltransferase (LCAT) possesses intrinsic PAF-AH-like activity, it also may represent a potential anti-inflammatory enzyme. The behavior of PAF-AH and LCAT in hepatobiliary inflammatory responses in vivo has not been characterized. We therefore investigated the biliary and plasma secretion and pharmacological characteristics of these enzymes in rats subjected to intraportal bacterial endotoxin exposure (lipopolysaccharide [LPS], Escherichia coli, 055:B5). Portal vein LPS infusion (1 mg/kg, bolus) resulted in a maximal 4- to 5-fold increase in bile PAF-AH-specific activity with a gradual decline to baseline by 18 hours. Biliary PAF-AH hydrolyzed also the truncated sn-2-succinoyl and sn-2-glutaroyl analogs of PAF, indicating a broader activity of PAF-AH in bile toward byproducts of glycerophospholipid peroxidation. Plasma PAF-AH activity was not altered 5 hours after LPS injection compared with saline injection, but it was significantly elevated 18 hours after endotoxin exposure. The levels of LCAT in bile were low and declined to nearly undetectable values by 5 hours after cannulation in both control and LPS-exposed rats. Plasma LCAT activity was significantly increased after 5 hours and decreased 18 hours after LPS injection. In summary, hepatic exposure to endotoxin results in a rapid increase in biliary secretion of PAF-AH followed by elevation of LCAT and PAF-AH levels in plasma. We propose that biliary secretion of PAF-AH may be involved in the hepatic response to endotoxic insult by counteracting potential inflammatory damage in the biliary tree and gastrointestinal tract, whereas plasma increases in LCAT and PAF-AH may promote elimination of excess PAF and oxidized phospholipids in the circulationKeywords
This publication has 33 references indexed in Scilit:
- Role of Kupffer cells in gut ischemia/reperfusion-induced hepatic microvascular dysfunction in miceHepatology, 1997
- Mammalian platelet-activating factor acetylhydrolasesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Purification, Properties, Sequencing, and Cloning of a Lipoprotein-Associated, Serine-Dependent Phospholipase Involved in the Oxidative Modification of Low-Density LipoproteinsArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Plasma Platelet-activating Factor Acetylhydrolase Is a Secreted Phospholipase A2 with a Catalytic TriadJournal of Biological Chemistry, 1995
- Potential etiologic role of PAF in two major septic complications; Disseminated intravascular coagulation and multiple organ failureThrombosis Research, 1994
- Endotoxin infusion primes elicited neutrophils and Kupffer cells for platelet-activating factor-induced and tripeptide formyl-methionine-leucine-phenylalanineinduced basal free intracellular calcium concentration responsesCritical Care Medicine, 1993
- PLATELET-ACTIVATING FACTOR IN HEPATIC ISCHEMIA/REPERFUSION INJURYTransplantation, 1993
- Endotoxin and Hypoxia-Induced Intestinal Necrosis in Rats: The Role of Platelet Activating FactorPediatric Research, 1992
- Platelet Activating Factor Stimulates and Primes the Liver, Kupffer Cells and Neutrophils to Release Superoxide AnionFree Radical Research Communications, 1992
- Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: Higher activities in hypertensive ratsBiochemical and Biophysical Research Communications, 1983